Acute effects of zolpidem on daytime alertness, psychomotor and physical performance

Sachiko Uemura Ito, Takashi Kanbayashi, Takaubu Takemura, Hideaki Kondo, Shoko Inomata, Gyongyi Szilagyi, Tetsuo Shimizu, Seiji Nishino

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In a double-blind cross-over study, seven athletes received zolpidem (10 mg) or placebo in two sessions over two nights. Residual effects on subsequent daytime functions were evaluated objectively by measuring psychomotor and physical performance using a combined test of finger dexterity, a simple discriminatory reaction test, critical flicker fusion test (CFF), vertical jump, and 50-m sprint, as well as subjectively, by visual analog scales. Zolpidem shortened self-estimated sleep latency and increased total sleep at nighttime. There was no change in alertness and fatigue scales on the following day in the zolpidem session, but realm of daytime well-being was slightly worsened. The CFF test showed significantly better results in the zolpidem group than in the placebo group. Zolpidem did not have effects in athletic evaluation. Zolpidem has a hypnotic activity without disturbing psychomotor and physical performance on the following day when given to healthy adults, suggesting zolpidem may be used in healthy athletes to adjust their extrinsic sleep disturbances and their consecutive psychomotor and physical impairments.

Original languageEnglish
Pages (from-to)309-313
Number of pages5
JournalNeuroscience Research
Volume59
Issue number3
DOIs
Publication statusPublished - Nov 1 2007

Fingerprint

Psychomotor Performance
Flicker Fusion
Sleep
Athletes
Psychomotor Disorders
Placebos
zolpidem
Hypnotics and Sedatives
Visual Analog Scale
Cross-Over Studies
Fingers
Sports
Fatigue

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Ito, S. U., Kanbayashi, T., Takemura, T., Kondo, H., Inomata, S., Szilagyi, G., ... Nishino, S. (2007). Acute effects of zolpidem on daytime alertness, psychomotor and physical performance. Neuroscience Research, 59(3), 309-313. https://doi.org/10.1016/j.neures.2007.07.009

Acute effects of zolpidem on daytime alertness, psychomotor and physical performance. / Ito, Sachiko Uemura; Kanbayashi, Takashi; Takemura, Takaubu; Kondo, Hideaki; Inomata, Shoko; Szilagyi, Gyongyi; Shimizu, Tetsuo; Nishino, Seiji.

In: Neuroscience Research, Vol. 59, No. 3, 01.11.2007, p. 309-313.

Research output: Contribution to journalArticle

Ito, SU, Kanbayashi, T, Takemura, T, Kondo, H, Inomata, S, Szilagyi, G, Shimizu, T & Nishino, S 2007, 'Acute effects of zolpidem on daytime alertness, psychomotor and physical performance', Neuroscience Research, vol. 59, no. 3, pp. 309-313. https://doi.org/10.1016/j.neures.2007.07.009
Ito SU, Kanbayashi T, Takemura T, Kondo H, Inomata S, Szilagyi G et al. Acute effects of zolpidem on daytime alertness, psychomotor and physical performance. Neuroscience Research. 2007 Nov 1;59(3):309-313. https://doi.org/10.1016/j.neures.2007.07.009
Ito, Sachiko Uemura ; Kanbayashi, Takashi ; Takemura, Takaubu ; Kondo, Hideaki ; Inomata, Shoko ; Szilagyi, Gyongyi ; Shimizu, Tetsuo ; Nishino, Seiji. / Acute effects of zolpidem on daytime alertness, psychomotor and physical performance. In: Neuroscience Research. 2007 ; Vol. 59, No. 3. pp. 309-313.
@article{7dcee98e0ede4285b8f65c36ec2d9661,
title = "Acute effects of zolpidem on daytime alertness, psychomotor and physical performance",
abstract = "In a double-blind cross-over study, seven athletes received zolpidem (10 mg) or placebo in two sessions over two nights. Residual effects on subsequent daytime functions were evaluated objectively by measuring psychomotor and physical performance using a combined test of finger dexterity, a simple discriminatory reaction test, critical flicker fusion test (CFF), vertical jump, and 50-m sprint, as well as subjectively, by visual analog scales. Zolpidem shortened self-estimated sleep latency and increased total sleep at nighttime. There was no change in alertness and fatigue scales on the following day in the zolpidem session, but realm of daytime well-being was slightly worsened. The CFF test showed significantly better results in the zolpidem group than in the placebo group. Zolpidem did not have effects in athletic evaluation. Zolpidem has a hypnotic activity without disturbing psychomotor and physical performance on the following day when given to healthy adults, suggesting zolpidem may be used in healthy athletes to adjust their extrinsic sleep disturbances and their consecutive psychomotor and physical impairments.",
author = "Ito, {Sachiko Uemura} and Takashi Kanbayashi and Takaubu Takemura and Hideaki Kondo and Shoko Inomata and Gyongyi Szilagyi and Tetsuo Shimizu and Seiji Nishino",
year = "2007",
month = "11",
day = "1",
doi = "10.1016/j.neures.2007.07.009",
language = "English",
volume = "59",
pages = "309--313",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Acute effects of zolpidem on daytime alertness, psychomotor and physical performance

AU - Ito, Sachiko Uemura

AU - Kanbayashi, Takashi

AU - Takemura, Takaubu

AU - Kondo, Hideaki

AU - Inomata, Shoko

AU - Szilagyi, Gyongyi

AU - Shimizu, Tetsuo

AU - Nishino, Seiji

PY - 2007/11/1

Y1 - 2007/11/1

N2 - In a double-blind cross-over study, seven athletes received zolpidem (10 mg) or placebo in two sessions over two nights. Residual effects on subsequent daytime functions were evaluated objectively by measuring psychomotor and physical performance using a combined test of finger dexterity, a simple discriminatory reaction test, critical flicker fusion test (CFF), vertical jump, and 50-m sprint, as well as subjectively, by visual analog scales. Zolpidem shortened self-estimated sleep latency and increased total sleep at nighttime. There was no change in alertness and fatigue scales on the following day in the zolpidem session, but realm of daytime well-being was slightly worsened. The CFF test showed significantly better results in the zolpidem group than in the placebo group. Zolpidem did not have effects in athletic evaluation. Zolpidem has a hypnotic activity without disturbing psychomotor and physical performance on the following day when given to healthy adults, suggesting zolpidem may be used in healthy athletes to adjust their extrinsic sleep disturbances and their consecutive psychomotor and physical impairments.

AB - In a double-blind cross-over study, seven athletes received zolpidem (10 mg) or placebo in two sessions over two nights. Residual effects on subsequent daytime functions were evaluated objectively by measuring psychomotor and physical performance using a combined test of finger dexterity, a simple discriminatory reaction test, critical flicker fusion test (CFF), vertical jump, and 50-m sprint, as well as subjectively, by visual analog scales. Zolpidem shortened self-estimated sleep latency and increased total sleep at nighttime. There was no change in alertness and fatigue scales on the following day in the zolpidem session, but realm of daytime well-being was slightly worsened. The CFF test showed significantly better results in the zolpidem group than in the placebo group. Zolpidem did not have effects in athletic evaluation. Zolpidem has a hypnotic activity without disturbing psychomotor and physical performance on the following day when given to healthy adults, suggesting zolpidem may be used in healthy athletes to adjust their extrinsic sleep disturbances and their consecutive psychomotor and physical impairments.

UR - http://www.scopus.com/inward/record.url?scp=34948830160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34948830160&partnerID=8YFLogxK

U2 - 10.1016/j.neures.2007.07.009

DO - 10.1016/j.neures.2007.07.009

M3 - Article

C2 - 17825448

AN - SCOPUS:34948830160

VL - 59

SP - 309

EP - 313

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 3

ER -